Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

ETR/DRW8 stock hub

ETR/DRW8 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/DRW8is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.5B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/DRW8

In the news

Latest news · ETR/DRW8

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E10.2

P25 12.3P50 15.7P75 20.2

Trailing P/E9.9

P25 16.4P50 20.9P75 30.4

ROE9.6

P25 -6.7P50 8.5P75 17.2

ROIC8.9

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/DRW8 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

222

Groups with data

Currency

EUR

Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	16,033
Employees Change	-90%
Employees Change Percent	-0.54
Enterprise value	EUR 1.6B
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Devices
Isin	DE0005550602
Last refreshed	2026-05-10
Market cap	EUR 1.5B
Price	EUR 72.4
Price currency	EUR
Rev Per Employee	218,768.1x
Sector	Healthcare
Sic	3841
Symbol	etr/DRW8
Website	https://www.draeger.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	10.15%
EV Earnings	10.35x
EV/EBIT	6.71x
EV/EBITDA	4.48x
EV/FCF	9.79x
EV/Sales	0.45x
FCF yield	10.72%
Forward P/E	10.19x
P/B ratio	0.91x
P/E ratio	9.85x
P/S ratio	0.43x
PE Ratio10 Y	17.98x
PE Ratio3 Y	9.4x
PE Ratio5 Y	10.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.71%
EBITDA Margin	8.68%
FCF margin	4.61%
Gross margin	45.32%
Gross Profit	EUR 1.6B
Gross Profit Growth	5.03%
Gross Profit Growth Q	4.55%
Gross Profit Growth3 Y	6.75%
Gross Profit Growth5 Y	-1.78%
Net Income	EUR 153M
Net Income Growth	32.79%
Net Income Growth Quarters	3%
Net Income Growth Years	3%
Net Income Growth5 Y	-11.24%
Pretax Margin	6.68%
Profit Margin	4.36%
Profit Per Employee	EUR 9,544
Profitable Years	3
ROA	4.72
Roa5y	2.89
ROCE	10.48
ROE	9.63
Roe5y	6.81
ROIC	8.86
Roic5y	7.24

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.03%
Cagr15y	2.39%
Cagr1y	47.08%
Cagr3y	24.41%
Cagr5y	1.03%
Div CAGR10	32.75%
Div CAGR3	157.13%
Div CAGR5	53.42%
EPS Growth Quarters	3
EPS Growth Years	3
FCF Growth	25.04%
FCF Growth Q	-11.27%
FCF Growth5 Y	-15.05%
OCF Growth	28.85%
OCF Growth Q	10.88%
OCF Growth10 Y	8.04%
OCF Growth5 Y	-12.87%
Revenue Growth	4.23x
Revenue Growth Q	3.51x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	3.57x
Revenue Growth5 Y	-0.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.13
Assets	EUR 3.2B
Cash	EUR 269.1M
Current Assets	EUR 1.9B
Current Liabilities	EUR 921.6M
Debt	EUR 342.2M
Debt EBITDA	EUR 0.97
Debt Equity	EUR 0.21
Debt FCF	EUR 2.12
Equity	EUR 1.7B
Interest Coverage	11.72
Liabilities	EUR 1.5B
Long Term Assets	EUR 1.3B
Long Term Liabilities	EUR 587.9M
Net Cash	EUR -73.2M
Net Cash By Market Cap	EUR -4.85
Net Debt EBITDA	EUR 0.24
Net Debt Equity	EUR 0.04
Net Debt FCF	EUR 0.45
Tangible Book Value	EUR 1.3B
WACC	6.67

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.07
Inventory Turnover	2.72
Net Working Capital	EUR 746.3M
Quick ratio	1.17
Working Capital	EUR 990.7M
Working Capital Turnover	EUR 3.85

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	12.18%
Dividend Growth Years	2%
Dividend per share	EUR 2.21
Dividend Years	17
Dividend Yield	3.18%
Ex Div Date	2026-05-11
Last Dividend	EUR 2.21
Payout Frequency	Annual
Payout Ratio	24.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	48.39%
1Y total return	47.04%
200-day SMA	62.76
3Y total return	92.59%
50-day SMA	71.6
50-day SMA vs 200-day SMA	50over200
5Y total return	5.27%
All Time High	90.1
All Time High Change	-19.64%
All Time High Date	2013-05-29
All Time Low	31.5
All Time Low Change	129.84%
All Time Low Date	2019-10-01
ATR	2.4
Beta	0.56
Ch YTD	28.37
High	73.2
High52	77.4
High52 Date	2026-04-17
High52ch	-6.46%
Low	71.6
Low52	47.5
Low52 Date	2025-05-12
Low52ch	52.42%
Ma50ch	1.11%
Price vs 200-day SMA	15.36%
RSI	51.76
RSI Monthly	64.1
RSI Weekly	57.88
Sharpe ratio	1.17x
Sortino ratio	2.05
Total Return	3.18%
Tr YTD	28.37
Tr15y	42.42%
Tr1m	-0.55%
Tr1w	4.32%
Tr3m	3.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 235.3M
Operating Income Growth	57.66
Operating Income Growth Q	1,968.3
Operating Income Growth5 Y	-14.9
Operating margin	6.71

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10,574,088%
Net Borrowing	-105,333,000
Shares Insiders	32.65%
Shares Institutions	18.67%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 161.7M
Average Volume	2,134.6x
CAPEX	EUR -82.7M
Ch10y	34.07
Ch15y	20.97
Ch1m	-0.55
Ch1w	4.32
Ch1y	41.41
Ch3m	3.43
Ch3y	77.45
Ch5y	-3.47
Ch6m	23.97
Change	0.56%
Change From Open	-0.28
Close	72
Days Gap	0.83
Depreciation Amortization	69,316,000
Dollar Volume	31,276.8
Earnings Date	2026-04-30
EBIT	EUR 235.3M
EBITDA	EUR 304.6M
F Score	7
FCF	EUR 161.7M
FCF EV Yield	10.21x
Financing CF	-130,850,000
Fiscal Year End	December
Founded	1,889
Graham Number	114.65905
Graham Upside	58.37
Income Tax	EUR 80.7M
Investing CF	-92,155,000
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Lynch Fair Value	EUR 36.74
Lynch Upside	-49.26
Ma150	65.24
Ma150ch	10.98%
Ma20	72.91
Ma20ch	-0.7%
Net CF	19,504,000
Next Earnings Date	2026-07-30
Open	72.6
P FCF Ratio	9.33
P OCF Ratio	6.17
Payment Date	2026-05-13
Position In Range	50
Ppne	559,722,000
Price Date	2026-05-08
Price EBITDA	EUR 4.95
Ptbv Ratio	1.14
Relative Volume	0.2x
Revenue	3,507,509,000x
Tax By Revenue	2.3x
Tax Rate	34.45%
Tr6m	23.97%
Volume	432
Z Score	2.81

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/DRW8 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.2%

$2.21 annual per share

Payout ratio

+24.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+53.4%

2 consecutive years of growth

Total shareholder yield

+3.2%

Next ex-dividend date: 2026-05-11

Performance

ETR/DRW8 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/DRW8?

Insider, institutional, and short-interest positioning.

Institutional ownership

+18.7%

Share of float held by funds and institutions

Insider ownership

+32.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

ETR/DRW8 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.8

Neutral momentum band

Price vs 200-day MA

+15.4%

50/200-day relationship not available

Beta (5Y)

0.56

Less volatile than the market

Sharpe ratio

1.17

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/DRW8

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/DRW8 stock rating?

etr/DRW8 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/DRW8 analysis?

The full report lives at /stocks/etr/DRW8/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/DRW8?

The latest report frames etr/DRW8 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/DRW8 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.